Data is not available at this time.
Care Twentyone Corporation operates as a leading provider of nursing care services in Japan, addressing the growing demand for elderly and disability support in an aging society. The company’s diversified service portfolio includes home-visit care, paid nursing homes, dementia group homes, and welfare equipment rentals, alongside ancillary businesses like meal delivery and employment support for people with disabilities. Its integrated approach ensures recurring revenue streams while catering to a broad demographic. Positioned in Japan’s highly regulated healthcare sector, Care Twentyone leverages its extensive network and operational expertise to maintain a competitive edge. The company’s focus on small-scale, community-based care aligns with government policies promoting decentralized elderly care, enhancing its market relevance. Additionally, its real estate development and human resource dispatch services create synergies, reinforcing its role as a comprehensive care solutions provider. With Japan’s aging population driving sustained demand, Care Twentyone is well-placed to capitalize on long-term industry tailwinds.
Care Twentyone reported revenue of JPY 45.4 billion for FY 2024, with net income of JPY 278 million, reflecting modest profitability in a cost-intensive sector. Operating cash flow stood at JPY 710 million, though capital expenditures of JPY -1.08 billion indicate ongoing investments in infrastructure. The company’s ability to generate positive cash flow despite high operational costs underscores its efficiency in a regulated, labor-driven industry.
The company’s diluted EPS of JPY 20.63 highlights its earnings capacity, though margins remain constrained by sector-wide labor and regulatory costs. With a beta of 0.41, Care Twentyone exhibits lower volatility compared to the broader market, suggesting stable earnings power. However, its capital efficiency is tempered by significant debt levels, which may limit near-term flexibility.
Care Twentyone’s balance sheet shows JPY 3.08 billion in cash against JPY 19.5 billion in total debt, indicating leveraged financial health. While the debt load is substantial, the company’s steady cash flow generation provides some cushion. The healthcare sector’s defensive nature may mitigate liquidity risks, but deleveraging could be a priority to improve long-term stability.
Growth is underpinned by Japan’s demographic trends, though near-term expansion may be tempered by high capex. The dividend payout of JPY 17 per share reflects a commitment to shareholder returns, albeit with a modest yield. Future growth will likely hinge on operational scalability and government policy support for elderly care services.
With a market cap of JPY 5.29 billion, Care Twentyone trades at a modest valuation, reflecting its niche positioning and debt burden. Investors likely price in steady but slow growth, given the sector’s structural tailwinds and regulatory constraints. The low beta suggests market expectations of resilience amid economic cycles.
Care Twentyone’s strategic advantage lies in its integrated service model and alignment with Japan’s aging population needs. While regulatory and cost pressures persist, the company’s diversified revenue streams and community-focused approach position it for sustainable, if gradual, growth. The outlook remains stable, with potential upside from policy tailwinds and operational efficiencies.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |